Showing results (111-120 of 122) with videos related to

Sort By:
Pageof 13
Blood|January 8, 2013
Genetic programs expressed in resting and IL-4 alternatively activated mouse and human macrophages: similarities and differencesFernando O Martinez, Laura Helming, Ronny Milde, et al.
F1000Research|February 10, 2021
The EU one-stop-shop collection of publicly available information on COVID-19 in vitro diagnostic medical devicesMauro Petrillo, Maddalena Querci, Olga Tkachenko, et al.
Blood Advances|June 29, 2022
The identification of TCF1+ progenitor exhausted T cells in THRLBCL may predict a better response to PD-1/PD-L1 blockadeValentina Tabanelli, Federica Melle, Giovanna Motta, et al.
Nature Immunology|April 27, 2021
Heme catabolism by tumor-associated macrophages controls metastasis formationFrancesca Maria Consonni, Augusto Bleve, Maria Grazia Totaro, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 30, 2010
Microenvironmental control of malignancy exerted by RNASET2, a widely conserved extracellular RNaseFrancesco Acquati, Sabrina Bertilaccio, Annalisa Grimaldi, et al.
Haematologica|August 21, 2020
A three-gene signature based on MYC, BCL-2 and NFKBIA improves risk stratification in diffuse large B-cell lymphomaEnrico Derenzini, Saveria Mazzara, Federica Melle, et al.
Trials|December 13, 2022
BORN study: a multicenter randomized trial investigating cord blood red blood cell transfusions to reduce the severity of retinopathy of prematurity in extremely low gestational age neonatesLuciana Teofili, Patrizia Papacci, Nicoletta Orlando, et al.
F1000Research|July 20, 2022
A roadmap for the generation of benchmarking resources for antimicrobial resistance detection using next generation sequencingMauro Petrillo, Marco Fabbri, Dafni Maria Kagkli, et al.
Transfusion|April 29, 2026
Cord blood red cell concentrates for preterm neonate transfusion: Insights from the multicenter BORN trialClaudio Pellegrino, Patrizia Papacci, Carlo Dani, et al.
Italian Journal of Pediatrics|August 7, 2024
Cord blood transfusions in extremely low gestational age neonates to reduce severe retinopathy of prematurity: results of a prespecified interim analysis of the randomized BORN trialLuciana Teofili, Patrizia Papacci, Carlo Dani, et al.
Pageof 13